کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3835695 | 1247396 | 2006 | 11 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Hipertensión arterial y sÃndrome metabólico
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
پزشکی و دندانپزشکی (عمومی)
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Patients with metabolic syndrome (MS) make up a priority group for the prevention and treatment of cardiovascular risk in Primary Health Care (PHC). Their identification based on clinical criteria recommended by the NCEP-ATP (National Colesterol Education Program-Adult Treatment Panel) III enormously facilitates the diagnosis in our setting. Insulin resistance (IR) constitutes the common pathogenic base of MS, although obesity and abdominal distribution of fat also have an important role, the relationship between some inflammation markers (proteine C reactive [PCR], interleucin 6 [IL-6], tumor necrosis factor alfa [TNF-α])” and MS being well-compared. Multifactorial intervention with adoption of healthy life styles should head the treatment of these patients. We do not have evidence that has demonstrated the superiority of an antihypertensive treatment subgroup over another in the future of cardiovascular events or mortality in the treatment of the patient with MS. However, the use of certain antihypertensive agents could be key due to their influence on IR. Adequate management of insulin sensitizing antidiabetic drugs may also be relevant to neutralize IR and the appearance of type 2 diabetes.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: SEMERGEN - Medicina de Familia - Volume 32, Issue 2, February 2006, Pages 73-83
Journal: SEMERGEN - Medicina de Familia - Volume 32, Issue 2, February 2006, Pages 73-83
نویسندگان
J.L. Llisterri Caro, M. Luque Otero,